Coronavirus Australia: Experimental ebola drug could treat COVID-19 patients in clinical trial
An experimental drug initially designed to treat ebola could soon be used to treat coronavirus patients in a clinical trial in Australia
The broad-spectrum antiviral remdesivir was originally developed by US drug firm Gilead to tackle the 2009 ebola outbreak, but ultimately proved unsuccessful.
Now it’s being used in several coronavirus clinical trials across the world, with some promising results.
Earlier this month, a 79-year-old Italian man who had tested positive to COVID-19